PATRICIA ESMERALDA
CARREIRA DELGADO
Profesora asociada de Ciencias de la Salud
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (53)
2024
-
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97
2023
-
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies
Rheumatology (United Kingdom), Vol. 62, Núm. 1, pp. 243-255
-
Immunoglobulins in systemic sclerosis management. A large multicenter experience
Autoimmunity Reviews, Vol. 22, Núm. 11
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
-
Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review
Seminars in Arthritis and Rheumatism, Vol. 52
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
-
SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients
Rheumatology (United Kingdom), Vol. 60, Núm. 6, pp. 2946-2957
2020
-
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
The Lancet Rheumatology, Vol. 2, Núm. 2, pp. e71-e83
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
-
LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients
Rheumatology International, Vol. 39, Núm. 11, pp. 1875-1882
2018
-
Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients
Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 1, pp. 22-27
-
Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations
PLoS ONE, Vol. 13, Núm. 1
2017
-
An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis
Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457
2016
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344
-
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway
Annals of the Rheumatic Diseases, Vol. 75, Núm. 8, pp. 1521-1526
-
LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition
Clinical and Experimental Rheumatology
2015
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
-
Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus
Arthritis and Rheumatology
-
Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis
American Journal of Human Genetics, Vol. 94, Núm. 1, pp. 47-61